Records containing: Psoriasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-10-03An Investigator-Initiated, Phase 4, Open-Label, Single-Arm, Single-Center Study Investigating the Residual Disease Memory in Psoriasis Skin During Enstilar® and Narrow-Band Ultraviolet B Therapy: The Mempsolar Study
-
CLINICAL_TRIALS study record update · 2025-10-03A Phase 2a, Proof of Concept Study Evaluating the Safety and Tolerability of AX-158 in Patients With Mild to Moderate Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2025-10-02Safety and Efficacy of RAP-103 in Dose of 400mg/Day/One Dose a Day, 200mg/Day Twice Dose a Day, or Placebo Administrated for 8 Weeks, to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects 18y to 70y: Randomized, Double Blind, Phase 2, Proof of Concept, Placebo Controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-09-26CARE: A CAnadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity
-
CLINICAL_TRIALS study record update · 2025-09-25A Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Tolerability and Clinical Response After 4-week Oral Treatment With SAR441566 Compared With Placebo in Participants With Mild to Moderate Psoriasis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-09-24A Multi-center, Single-arm, Open-label, Phase 4 Clinical Study to Evaluate the Efficacy and Safety of Apremilast in Patients With Moderate-to-severe Psoriasis
-
CLINICAL_TRIALS study record update · 2025-09-19A Pilot Double-Blind Randomized Controlled Trial on the Efficacy and Safety of a Novel Skin Barrier Product Versus Petrolatum in Individuals With Skin Barrier Dysfunction
-
CLINICAL_TRIALS study record update · 2025-09-17Prospective Observational Cohort Study of Patients With Moderate to Severe Chronic Plaque Psoriasis in Taiwan
-
CLINICAL_TRIALS study record update · 2025-09-16Prospective, Observational Study Brodalumab Compared With Other Therapies in the Treatment of Adults With Moderate-to-Severe Psoriasis Who Are Candidates for Systemic Therapy or Phototherapy in the Course of Actual Clinical Care
-
CLINICAL_TRIALS study record update · 2025-09-16An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects (6 to < 18 Years Old) With Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2025-09-15PSOCADIA: Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
-
CLINICAL_TRIALS study record update · 2025-09-12Effects of IL17/23 Inhibitors on Markers of Subclinical Atherosclerosis in Patients With Psoriasis: an Observational Study
-
CLINICAL_TRIALS study record update · 2025-09-10A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting
-
CLINICAL_TRIALS study record update · 2025-09-10Comparative Study of the Efficacy, Safety, and Immunogenicity of CMAB015 and Secukinumab in Adult Patients With Moderate-severe Chronic Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2025-09-08OTEZLA® Tablets Drug Use-Results Survey
-
CLINICAL_TRIALS study record update · 2025-09-05Role of Th17 and Stress-related Neuroendocrine Markers in the Pathogenesis of Periodontal Disease in Individuals With Psoriasis
-
CLINICAL_TRIALS study record update · 2025-09-04Periodontal Status and Quality of Life in Patients With Psoriasis: A Cross-Sectional Study
-
CLINICAL_TRIALS study record update · 2025-09-02A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers
-
CLINICAL_TRIALS study record update · 2025-09-02Evaluation of Tolerability, Efficacy and Adherence to Treatment With Wynzora Cream in Patients With Psoriasis Previously Treated With Enstilar Foam.
-
CLINICAL_TRIALS study record update · 2025-09-02A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2025-09-02Analysis of Influence Factors on Osteopenia in Different Treatment of Psoriasis
-
CLINICAL_TRIALS study record update · 2025-08-27A Phase 4, Open-Label, Multicenter Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Suppression Potential of Topically Applied IDP-122 Lotion in Pediatric Subjects With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2025-08-26Characterization of the Fungal Immunopeptidome Involved in the Immunopathological Mechanisms of Psoriasis
-
CLINICAL_TRIALS study record update · 2025-08-22Effectiveness of a Digital Health Application for Psoriasis: Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-08-22Impact of Clinical and Psychological Factors on Treatment Satisfaction in Psoriatic Patients in Biological Therapy